These companies have impressive track records of navigating the biggest challenges in their industry.

This rising AI stock has promising ingredients for huge long-term returns.

MP Materials stock is back to flat after its earnings beat, and poised for sales growth.

Nordson has outpaced the Nasdaq Composite over the past year, although analysts retain a cautiously optimistic view on the company’s forward growth outlook.

Revvity has lagged the broader S&P 500 over the past year, though analysts maintain a cautiously positive outlook on its forward growth potential.

Pentair has outperformed its industry peers over the past year, although analysts maintain a cautiously optimistic outlook on the stock’s future performance.

Stanley Black & Decker has lagged the broader Dow Jones Industrial Average over the past year, though analysts maintain a cautiously optimistic outlook on its future performance.

Money market account rates vary widely. So which banks are offering the best money market account rates today? Find out here.

Abivax and Nektar Therapeutics are clinical-stage biotech companies that would make attractive buyout targets.

Oracle stock popped following its latest quarterly report, driven by its better-than-expected results and improved guidance.

Robinhood's business is showing cracks, which is causing investors to rethink the company's sky-high valuation.

These great dividend stocks are especially attractive in the current market conditions.

Berkshire Hathaway's new CEO thinks highly of the company's shares.

The dominant consumer brand's share price is up 10,590% in the past 20 years.

These stocks can quietly do the grunt work in your portfolio -- and make you richer.